The Valley Desk

NCT00281957 · Interventional trial

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

Overall registry status Completed

Phase 2

Conditions Recurrent Melanoma, Stage IV Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov